About Medicilon
Fully Integrated Preclinical Drug Discovery and Development Services
Medicilon is an integrated contract research organization (CRO), providing comprehensive one-step new drug R&D for pharmaceutical enterprises and scientific research institutions around the world. With our experience in serving domestic and foreign biomedical industries, we have built an integrated technical platform covering key technologies in drug discovery, pharmaceutical research, and preclinical research, in a bid to provide comprehensive preclinical new drug R&D for the global biomedical industry.
At Medicilon, we are dedicated to help our clients develop their research and discovery programs from initial idea all the way through the Investigational New Drug (IND) filing phase. Our services span across medicinal chemistry, biology, API, CMC, formulation, and preclinical studies. We provide flexible business models, including stand-alone Fee for Services (FFS) and fully integrated FTE services. In addition, our facilities are GLP/GMP compliant, US-FDA, China NMPA and AAALAC accredited. All study reports can be presented in SEND format, supporting dual filing of IND applications in the US, EU, and China.
18+
18+ years of experience in new drug R&D
1710+
Active clients worldwide
2800+
Newdrug discovery scientists and service personnel
81600+
Square meters of Laboratory floor space
268
Projects successfully approved with FDA, NMPA, EMA, and TGA
Drug Discovery
❖Medicinal Chemistry
❖Biology Services
CMC Services
❖Intermediates
❖APIs
❖Pharmaceutic Formulation
Preclinical Studies
❖Pharmacodynamics
❖Pharmacokinetics
❖Drug Safety Evaluation
❖IND Filing
One-stop Integrated Services Platform
❖PROTAC Drug Discovery Research Platform
❖Antibody-Drug Conjugate(ADC) R&D Service Platform
❖Nucleic Acid Drug R&D Platform
❖Cytokine and Biomarker Detection Platform
❖Flow Cytometry Technology Platform
❖mRNA Vaccine Bioanalysis Platform
❖Pharmaceutical Research CDMO Service Platform
❖Process Department Solid Form Screening Platform
❖Inhalation drug R&D platform
❖Skin Topical Preparation R&D
❖IO Pharmacodynamic Model Evaluation Platform
❖Cellular Immunotherapies R&D platform
❖Ophthalmic drug R&D platform